http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005502029-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
filingDate | 2002-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2005502029-A |
titleOfInvention | Novel method for measuring apo CIII in apo B and non-apo B containing particles |
abstract | The present invention relates to a novel method for measuring apolipoprotein CIII (“apo CIII”) in apo B and non-apo B containing lipoparticles. The present invention also includes synthetic apo CIII products, corresponding antibodies, kits containing the same, and for detecting, quantifying and / or monitoring apo CIII levels in a sample, as well as atherogenic lipo in a sample. It also relates to its use for quantifying and / or monitoring particle levels. The compounds and kits described above can also be used to modulate apo CIII levels or activity in vitro or in vivo and to regulate lipid metabolism in a subject. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015148621-A |
priorityDate | 2001-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.